CFDE Data Portal | Search RPS14P1

	Label	Description
	RPS14P1 Gene (Entity type)	ENSG00000224114 - ribosomal protein S14 pseudogene 1
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE220806 progesterone fibroblast 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE101754 FXR1 knockdown NCI-H358 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE186709 GSE186711 MLL inhibition 4 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 14 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE186709 GSE186711 MLL inhibition 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE101754 FXR1 knockdown NCI-H358 5 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE81796 enzalutamide LNCaP C4-2 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

RPS14P1

ENSG00000224114 - ribosomal protein S14 pseudogene 1

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn

A Gene Set from LINCS

GSE220806 progesterone fibroblast 1 v 3 human dn

A Gene Set from LINCS

GSE261563 CX-5461 6 v 1 human up

A Gene Set from LINCS

GSE101754 FXR1 knockdown NCI-H358 5 v 2 human dn

A Gene Set from LINCS

GSE186709 GSE186711 MLL inhibition 4 v 6 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 14 v 10 human dn

A Gene Set from LINCS

GSE186709 GSE186711 MLL inhibition 3 v 6 human dn

A Gene Set from LINCS

GSE101754 FXR1 knockdown NCI-H358 5 v 3 human dn

A Gene Set from LINCS

GSE81796 enzalutamide LNCaP C4-2 0 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.